A synthetic biology company building biosensors capable of measuring chemicals and small molecules within living cells.
On November 15, 2016 Prospect Bio announced raising $2.8 million in seed funding from Viking Global Investors, Viaduct Ventures, Think + Ventures, StartX, Rising Tide, Pallasite Ventures, OS Fund, Illumina, GVA LaunchGurus Fund, and 500 Startups.
Prospect Bio is a synthetic biology company building biosensors capable of measuring chemicals and small molecules within living cells that is headquartered in Brisbane, California and was founded in 2013 by Cameron StrachanCameron Strachan and Giles Ochs. The company claims on their TROVE biosensor library has more than 10^9 naturally sourced biosensors.